Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-292714
Filing Date
2023-12-11
Accepted
2023-12-11 17:22:34
Documents
6
Effectiveness Date
2023-12-11

Document Format Files

Seq Description Document Type Size
1 S-8 d543139ds8.htm S-8 50736
2 EX-5.1 d543139dex51.htm EX-5.1 4934
3 EX-23.1 d543139dex231.htm EX-23.1 1959
4 EX-FILING FEES d543139dexfilingfees.htm EX-FILING FEES 13025
5 GRAPHIC g543139g1030203659110.jpg GRAPHIC 4525
6 GRAPHIC g543139g1030203659282.jpg GRAPHIC 6037
  Complete submission text file 0001193125-23-292714.txt   86530
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275990 | Film No.: 231479030
SIC: 2834 Pharmaceutical Preparations